Patents Assigned to iSense Corporation
  • Patent number: 8845530
    Abstract: A device, system, and method for delivering a device such as a sensor or fluid transport structure or a fluid transport structure sensor combination into, for example, mammalian skin and receiving, analyzing, and displaying signals from the device such as a sensor are disclosed. A system in accordance with embodiments of the present invention includes a reusable sensor assembly including a transmitter, microcontroller, and housing plus a disposable sensor assembly including a housing having an opening for receiving both the distal end of a biosensor, a sensor insertion guidance structure, and a transmission apparatus for transmitting signals received from the sensor to a reusable sensor assembly for transmission to an external electronic monitoring unit.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: September 30, 2014
    Assignee: iSense Corporation
    Inventors: Robert Bruce, Richard G. Sass, W. Kenneth Ward
  • Patent number: 8631679
    Abstract: Embodiments provide a method and related systems that take into account the difference between a measured glucose value and the calibration level and the amount of elapsed time since the prior calibration. As one or both of these determined differences increases, the desirability of an additional calibration also increases. The methodology described herein thus analyzes the combination of change in glucose level as well as the time since the prior calibration. If the combination exceeds a predetermined value, the system recommends, but does not require, that the subject user perform an additional calibration.
    Type: Grant
    Filed: September 4, 2009
    Date of Patent: January 21, 2014
    Assignee: iSense Corporation
    Inventors: Daniel Kaplan, W. Kenneth Ward
  • Patent number: 8629769
    Abstract: Systems and techniques for command communication between wireless devices are described. In one implementation, a data gathering device (such as a continuous glucose monitor) and a monitoring/control device, which communicate data samples through a frequency hopping protocol, utilize a dedicated command frequency for the transmission of non-data instructions and acknowledgements. A command mode is described where the command frequency is regularly listened to by a device to determine if pairing or other instructions are being sent. In another example, when communications are disrupted or corrupted, the devices revert to using the command frequency in order to reacquire a paired link between the devices. The command frequency is also used for a flight mode, where the data-acquisition device goes into a low-, or no-power transmission mode and remains in the mode, storing sampled data, until instructed to leave the flight mode over the command frequency.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: January 14, 2014
    Assignee: iSense Corporation
    Inventor: Robert Bruce
  • Patent number: 8483792
    Abstract: Embodiments herein provide an analyte sensor subassembly that provides an integrated structure enabling suitably secure electrical contact between an analyte sensor and the electronic components of an analyte sensor assembly. An analyte sensor subassembly assists the process of inserting the sensor into skin. An analyte sensor subassembly may operate in concert with one or more sensor insertion tools to provide insertion of an analyte sensor into the skin of a subject/patient. Associated devices, such as channel guides and sensor insertion tools, are also provided, as are methods of operation and sensor insertion.
    Type: Grant
    Filed: March 17, 2009
    Date of Patent: July 9, 2013
    Assignee: iSense Corporation
    Inventors: Dennis Slomski, Robert Bruce, Jon Fortuna, David B. Kreitlow
  • Publication number: 20120265042
    Abstract: A device and method for delivering a device such as a sensor or fluid transport structure or a fluid transport structure sensor combination into, for example, mammalian skin. Such a device allows a sensor to penetrate mammalian skin without the use of an introducer device such as a needle. A device in accordance with embodiments of the present disclosure includes a housing for attachment to mammalian skin including an exit port for receiving the distal end of a biosensor and an injection activation device including a mechanism for forcing the sensing device from a first position within the housing, through the exit port to a second position, with sufficiently high velocity to partially penetrate the mammalian skin.
    Type: Application
    Filed: March 8, 2012
    Publication date: October 18, 2012
    Applicant: iSense Corporation
    Inventors: Mark Neinast, Robert Bruce, W. Kenneth Ward, Richard G. Sass, Jon Fortuna
  • Patent number: 8187433
    Abstract: A sensing element adapted to, at least in part, be inserted into a mammalian body. The sensing element is made up of a core of a structurally robust metal and a plated portion made of an electrochemically active metal conjoined to at least a portion of the core. This sensing element may be used as part of a method for the continuous or intermittent monitoring of an analyte within a mammalian body. The method includes inserting at least a portion of the sensing element into the mammalian body and measuring any electric current produced by at least of portion of the sensor.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: May 29, 2012
    Assignee: iSense Corporation
    Inventors: W. Kenneth Ward, Richard G. Sass
  • Patent number: 8079955
    Abstract: Embodiments of the present invention provide methods, apparatuses, and systems associated with detecting, analyzing, and/or displaying historical glucose levels and/or trends in a body.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: December 20, 2011
    Assignee: iSense Corporation
    Inventors: W. Kenneth Ward, Richard Sass, Robert Bruce
  • Publication number: 20110282172
    Abstract: Embodiments provide an analyte sensing device having one or more indicating electrodes adapted for long-term use within an individual. An indicating electrode coupled with a reference electrode may be inserted within or below the dermis of an individual and may be electrically coupled to an external sensor unit. Related analyte sensor insertion aids and methods of using the disclosed embodiments are also provided.
    Type: Application
    Filed: November 9, 2009
    Publication date: November 17, 2011
    Applicant: ISENSE CORPORATION
    Inventor: Richard G. Sass
  • Patent number: 7976466
    Abstract: Embodiments of the present invention improve the accuracy of measurements and/or in vivo calibrations of a biosensor by (1) using more than one sensor signal value and/or more than one directly sampled and measured value, such as a capillary blood glucose value, and/or by (2) delaying the acquisition of a sensor output value that is compared with a directly sampled and measured value, such as a capillary blood glucose value, during a calibration. In an embodiment of the present invention, the median of a series of measured values, or a median or mean of the medians, may be utilized to provide more consistent and accurate measurement data and/or to compensate for error or artifact.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: July 12, 2011
    Assignee: Isense Corporation
    Inventors: W. Kenneth Ward, Peter G. Jacobs
  • Patent number: 7970449
    Abstract: Embodiments of the present invention provide for raising a background current setting for a biosensor above the actual (measured) background current present (i.e., overestimating the background current), particularly in the hypoglycemic range, to improve sensor accuracy and decrease the chance of glucose value overestimation by the sensor.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: June 28, 2011
    Assignee: Isense Corporation
    Inventor: W. Kenneth Ward
  • Publication number: 20110056264
    Abstract: Embodiments provide a method and related systems that take into account the difference between a measured glucose value and the calibration level and the amount of elapsed time since the prior calibration. As one or both of these determined differences increases, the desirability of an additional calibration also increases. The methodology described herein thus analyzes the combination of change in glucose level as well as the time since the prior calibration. If the combination exceeds a predetermined value, the system recommends, but does not require, that the subject user perform an additional calibration.
    Type: Application
    Filed: September 4, 2009
    Publication date: March 10, 2011
    Applicant: ISENSE CORPORATION
    Inventors: Daniel Kaplan, W. Kenneth Ward
  • Patent number: 7862519
    Abstract: A multiple use analyte sensing assembly that includes a long, thin conductor. A plurality of sensing sites are spaced along the conductor and each sensing site includes a membrane system adapted to create a current when placed into contact with body fluid containing the analyte. The assembly also includes a housing, having an aperture, an uptake spool and a payout spool, the conductor being wrapped about the payout spool before the sensing assembly is used. A sensor positioning actuator turns the uptake spool to move each sensing site, in sequence, to the housing aperture and then to the uptake spool. The assembly also includes a skin broaching assembly, having a multiplicity of lancets and a lancet positioning actuator adapted to move each lancet to the aperture. In addition, a lancet use actuator is adapted to move each lancet at least partially through the aperture and then back again.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: January 4, 2011
    Assignee: Isense Corporation
    Inventors: W. Kenneth Ward, Richard G. Sass
  • Publication number: 20100331642
    Abstract: Embodiments provide a sensor insertion tool (SIT) that provides a motive force for insertion of an analyte sensor into/through skin. A SIT may be releasably locked to one or more components of a sensor insertion system, such that components of the sensor insertion system remain securely coupled during sensor insertion. A SIT may include a release member that unlocks or uncouples the SIT and the other components after sensor insertion. In various embodiments, a SIT may be a component of a sensor insertion system configured for assembly by an end user, a health care professional, and/or a caretaker prior to sensor insertion, and may act in cooperation with other sensor insertion system components. Additional components and methods of assembly and use are also provided herein.
    Type: Application
    Filed: June 30, 2009
    Publication date: December 30, 2010
    Applicant: ISENSE CORPORATION
    Inventors: Robert Bruce, David Kreitlow, Isaac Federiuk, Ryan Polcin, Dennis Slomski, Eric Ward, Mihai Resch
  • Publication number: 20100198031
    Abstract: Embodiments of the present invention provide for raising a background current setting for a biosensor above the actual (measured) background current present (i.e., overestimating the background current), particularly in the hypoglycemic range, to improve sensor accuracy and decrease the chance of glucose value overestimation by the sensor.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 5, 2010
    Applicant: iSense Corporation
    Inventor: W. Kenneth Ward
  • Patent number: 7729737
    Abstract: Embodiments of the present invention provide for raising a background current setting for a biosensor above the actual (measured) background current present (i.e., overestimating the background current), particularly in the hypoglycemic range, to improve sensor accuracy and decrease the chance of glucose value overestimation by the sensor.
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: June 1, 2010
    Assignee: ISense Corporation
    Inventor: W. Kenneth Ward
  • Patent number: 7687586
    Abstract: Embodiments of the present invention provide various multipolymers and permselective membranes for use with biosensors and other implantable medical devices and prostheses. Embodiments of the present invention may provide structural strength and integrity, and further may control the influx of glucose, oxygen and/or water. Embodiments of the present invention may, for example, minimize or reduce the influx of glucose by minimizing the percentage of hydrophilic segments, which in turn minimizes the percentage of water uptake and the degree of glucose transport.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: March 30, 2010
    Assignee: Isense Corporation
    Inventors: Robert S. Ward, Yuan Tian, W. Kenneth Ward, Ellen Anderson, Jody House
  • Publication number: 20100052899
    Abstract: Systems and techniques for command communication between wireless devices are described. In one implementation, a data gathering device (such as a continuous glucose monitor) and a monitoring/control device, which communicate data samples through a frequency hopping protocol, utilize a dedicated command frequency for the transmission of non-data instructions and acknowledgements. A command mode is described where the command frequency is regularly listened to by a device to determine if pairing or other instructions are being sent. In another example, when communications are disrupted or corrupted, the devices revert to using the command frequency in order to reacquire a paired link between the devices. The command frequency is also used for a flight mode, where the data-acquisition device goes into a low-, or no-power transmission mode and remains in the mode, storing sampled data, until instructed to leave the flight mode over the command frequency.
    Type: Application
    Filed: August 27, 2009
    Publication date: March 4, 2010
    Applicant: ISENSE CORPORATION
    Inventor: Robert Bruce
  • Publication number: 20090234212
    Abstract: Embodiments herein provide an analyte sensor subassembly that provides an integrated structure enabling suitably secure electrical contact between an analyte sensor and the electronic components of an analyte sensor assembly. An analyte sensor subassembly assists the process of inserting the sensor into skin. An analyte sensor subassembly may operate in concert with one or more sensor insertion tools to provide insertion of an analyte sensor into the skin of a subject/patient. Associated devices, such as channel guides and sensor insertion tools, are also provided, as are methods of operation and sensor insertion.
    Type: Application
    Filed: March 17, 2009
    Publication date: September 17, 2009
    Applicant: iSense Corporation
    Inventors: Dennis Slomski, Robert Bruce, Jon Fortuna, David B. Kreitlow
  • Patent number: 7529574
    Abstract: A method of creating an analyte sensor. The method starts with the step of providing an electrochemically active surface. Then, at least one nub made of dielectric material and extending transversely outwardly from the electrochemically active surface is created. A curable liquid is applied to the electrochemically active surface and the nub and is then cured. In this process, the nub, which could be one of several nubs, serves to support the liquid before and during the curing.
    Type: Grant
    Filed: August 14, 2003
    Date of Patent: May 5, 2009
    Assignee: iSense Corporation
    Inventors: Lawrence B. Jansen, W. Kenneth Ward, Ellen Anderson
  • Patent number: RE43187
    Abstract: A method of measuring an analyte concentration in body fluid. The method includes the use of an analyte measuring device that has an analyte sensing element with a sharpened distal end and further has an indicating electrode covered by an absorbent layer. Also, an electric power, data processing and display device is adapted to mate to and activate the analyte sensing element by applying electric power to it and adapted to receive the raw analyte measurement and to compute and display a refined analyte measurement from the raw analyte measurement. The analyte sensing element is introduced into the animal body, thereby placing the absorbent layer into contact with the body fluid. The absorbent layer becomes saturated with body fluid and the analyte sensing element is removed from the body and is activated to form a raw analyte measurement. Which which is used to form and display a refined analyte measurement.
    Type: Grant
    Filed: October 9, 2008
    Date of Patent: February 14, 2012
    Assignee: iSense Corporation
    Inventors: Geoffrey A. Russell, W. Kenneth Ward, Ellen M. Anderson, Jonathan D. Birck